These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26166153)

  • 1. Childhood maltreatment and transition to psychotic disorder independently predict long-term functioning in young people at ultra-high risk for psychosis.
    Yung AR; Cotter J; Wood SJ; McGorry P; Thompson AD; Nelson B; Lin A
    Psychol Med; 2015 Dec; 45(16):3453-65. PubMed ID: 26166153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A; Wood SJ; Nelson B; Brewer WJ; Spiliotacopoulos D; Bruxner A; Broussard C; Pantelis C; Yung AR
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
    Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
    JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood trauma and clinical outcome in patients at ultra-high risk of transition to psychosis.
    Kraan T; van Dam DS; Velthorst E; de Ruigh EL; Nieman DH; Durston S; Schothorst P; van der Gaag M; de Haan L
    Schizophr Res; 2015 Dec; 169(1-3):193-198. PubMed ID: 26585219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term employment among people at ultra-high risk for psychosis.
    Cotter J; Lin A; Drake RJ; Thompson A; Nelson B; McGorry P; Wood SJ; Yung AR
    Schizophr Res; 2017 Jun; 184():26-31. PubMed ID: 27903412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial.
    Bolt LK; Amminger GP; Farhall J; McGorry PD; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Thompson A; Yung AR; Allott KA
    Schizophr Res; 2019 Apr; 206():67-74. PubMed ID: 30558978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive predictors of transition to psychosis: medium- to long-term findings from a sample at ultra-high risk for psychosis.
    Lin A; Yung AR; Nelson B; Brewer WJ; Riley R; Simmons M; Pantelis C; Wood SJ
    Psychol Med; 2013 Nov; 43(11):2349-60. PubMed ID: 23388122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
    Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
    Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.
    Allott KA; Schäfer MR; Thompson A; Nelson B; Bendall S; Bartholomeusz CF; Yuen HP; McGorry PD; Schlögelhofer M; Bechdolf A; Amminger GP
    Schizophr Res; 2014 Mar; 153(1-3):25-31. PubMed ID: 24552619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.
    Yung AR; Phillips LJ; Yuen HP; McGorry PD
    Schizophr Res; 2004 Apr; 67(2-3):131-42. PubMed ID: 14984872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying neurocognitive markers for outcome prediction of global functioning in individuals with first-episode and ultra-high-risk for psychosis.
    Sawada K; Kanehara A; Sakakibara E; Eguchi S; Tada M; Satomura Y; Suga M; Koike S; Kasai K
    Psychiatry Clin Neurosci; 2017 May; 71(5):318-327. PubMed ID: 28294477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study.
    Thompson A; Nelson B; Yung A
    Schizophr Res; 2011 Mar; 126(1-3):51-7. PubMed ID: 21035313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal patterns of social functioning and conversion to psychosis in subjects at ultra-high risk.
    Jang JH; Shin NY; Shim G; Park HY; Kim E; Jang GE; Kwon SJ; Hur JW; An SK; Kwon JS
    Aust N Z J Psychiatry; 2011 Sep; 45(9):763-70. PubMed ID: 21827349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.